Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Baricitinib effectively regrew hair in a woman with alopecia universalis after other treatments failed.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib can help about 14,000 people with severe hair loss.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Gefitinib can cause rare scarring hair loss.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.